Our Vision

To become the global leader in AI-powered neurotechnology — making brain health monitoring as routine and accessible as checking your heart rate.

We envision a world where mental health conditions are detected early, cognitive performance is optimized scientifically, and every individual has access to personalized neural intelligence.

Our Mission

To develop clinically validated, AI-enabled BCI solutions that bridge the gap between neuroscience research and real-world healthcare applications.

  • Democratize access to neurofeedback technology
  • Accelerate neuroscience research through open platforms
  • Achieve regulatory excellence (CDSCO, CE, FDA pathway)
  • Build India's first commercial BCI product company

Our Innovation Story

From research hypothesis to regulatory-approved platform — a timeline of dedication.

2019
Research Inception

Dr. Anil Patil and the SIT Biomedical Engineering team begin investigating EEG-based cognitive state detection using consumer-grade hardware.

2020
First Prototype

Development of the first SIU BehaveNeu EEG prototype with 4-channel signal acquisition and basic MATLAB-based analysis pipeline.

2021
Nexactly Partnership

Strategic collaboration established with Nexactly AI Solutions for commercial-grade AI model development and mobile app creation.

2022
NeuroBand v1 Launch

Launch of the first NeuroBand wearable with 8 EEG channels, BLE 5.0 connectivity, and LSTM-CNN deep learning integration.

2023
Clinical Trials

IRB-approved pilot study with 500+ subjects across SIU hospitals, yielding 12+ Scopus-indexed publications.

2024
CDSCO MD-13 Approval

Landmark regulatory approval from Central Drugs Standard Control Organisation as a Class B medical device.

2025
Patents & Commercialization

3 patents filed; Technology Transfer Agreement signed; NeuroBand 2.0 launched with 16 channels and AI emotion recognition.

2026
Global Expansion

Partnerships with international research institutions; targeting CE Mark and FDA 510(k) pathway for global markets.

SIU × Nexactly AI

A powerful academic-industry collaboration driving neurotechnology from lab bench to commercial product.

🏛️

Symbiosis International University

India's premier deemed university (NAAC A++ Grade) with world-class research facilities in biomedical engineering, neuroscience, and computational sciences.

  • Clinical research infrastructure & IRB approval
  • World-class faculty and Ph.D. researchers
  • Hospital network for clinical validation
  • IP generation & technology transfer support
Collaboration
🤖

Nexactly AI Solutions

A Pune-based deep-tech AI company specializing in embedded intelligence, mobile applications, and industrial AI deployments across healthcare and EdTech.

  • LSTM-CNN model development & optimization
  • iOS & Android mobile app engineering
  • Cloud infrastructure & API development
  • Commercialization & go-to-market strategy

Our Leadership Team

Multidisciplinary experts at the intersection of neuroscience, AI, and healthcare innovation.

AP
Dr. Anil Patil
Principal Investigator & Chief Scientist
Ph.D. Biomedical Engineering, SIT Pune. 15+ years in BCI research, 40+ publications. Pioneer of India's first consumer EEG platform.
MK
Dr. Meera Kulkarni
Co-Investigator, AI & ML
Ph.D. Computer Science, IIT Bombay. Expert in deep learning for time-series neural data, TensorFlow contributor, IEEE Senior Member.
RS
Rahul Sharma
CEO, Nexactly AI Solutions
MBA + BE Electronics. Serial entrepreneur with 2 successful exits. Driving SIU BehaveNeu's commercial strategy, partnerships, and fundraising.
SN
Dr. Sunita Nair
Clinical Research Director
MD Neurology, KEM Hospital, Mumbai. Heads clinical validation, ethics oversight, and hospital partnership program.
AD
Arjun Desai
CTO & Lead Engineer
M.Tech Signal Processing, IISc. Designed EEG hardware stack, BLE firmware, and real-time signal processing pipeline.
PS
Priya Shah
Head of Product & UX
B.Des NID Ahmedabad + MBA. Leads mobile app design, user research, and neurofeedback UX with a focus on clinical usability.

Join Our Research Journey

Collaborate with us as a clinical partner, research institution, or industry sponsor.